CALCRL and prostate carcinoma: Because prostate cancer patients develop bone metastasis at a later stage, we investigated the roles of CRLR and RAMPs in prostate cancer progression using a prostate cancer patient cohort (n = 390) in The Cancer Genome Atlas (Fig 4A).